From Isolation to Infrastructure – The Origins of Rare Disease Networks (blog 1/5)
Across the world, an estimated 300 to 400 million people live with a rare disease. Yet for most of the twentieth century, these individuals lived
Across the world, an estimated 300 to 400 million people live with a rare disease. Yet for most of the twentieth century, these individuals lived
The Day Something Felt “Not Quite Right” One ordinary day, I suddenly had a nosebleed. That alone isn’t unusual—I’ve had them before. But this time,
By Leigh Hart, Senior Moderator @ LDA Research Rare diseases affect an estimated 300–400 million people worldwide, yet progress in diagnosis and treatment has historically
At LDA Research, we know that behind every data point is a real person, a real family, and a real story. We’re sharing one of
If 2024 was the year medicine proved that steady, methodical progress could deliver profound impact without spectacle, 2025 is the year those advances began to
In rare diseases, patients aren’t on the sidelines – they are central partners. Their lived experience fills critical evidence gaps and shapes what “meaningful outcomes”
At LDA Research, we know that behind every data point is a real person, a real family, and a real story. We’re sharing one of
Senior moderator Leigh Hart explores the role of pharmaceutical companies in the Rare Disease Networks, what was planned and how it has worked out. Rare
Our senior research manager and blog contributor Rachel Barnes is celebrating working with LDA Research for a decade. Here she shares her secrets to successful
LDA Research has recently welcomed Julia Heck to our team as Senior Research Manager. Market research holds a special place in Julia’s heart as she
This month we profile Viviana Horwood, one of our research managers, who has worked with LDA Research for six and a half years and become
Feature Interview with LDA Research Founder, Lucy Doorbar. LDA Research provides global pharmaceutical & medical qualitative research. 01525 861436